{"count":10,"index":{"built_at":"2026-07-28T07:08:31.940207+00:00","public_records":55311,"revision":"16a019309cdbcfe047a09ddd"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: Longevity DNA Test in the context of menopause"},"results":[{"answer":"The query asks for an evidence check on a 'Menopause Check' in the context of longevity. The provided knowledge contexts contain no direct information about such a test. Existing sources cover DNA tests for metabolism, alcohol intolerance, or collagen – not menopause. A menopause check measuring biomarkers like FSH, estradiol, or genetic variants in estrogen metabolism could theoretically indicate hormonal status. However, evidence linking it directly to longevity is weak. Menopause is a natural transition; hormone replacement therapy has benefits and risks that require individual assessment. Without robust clinical trials or guidelines recommending such a check for longevity, its predictive value remains limited. Many commercial tests overstate their utility. Therefore, the evidence level is 'unclear' or 'marketing'. Safety note: Hormonal self-tests without medical supervision can lead to misinterpretation.","area":"gesundheit","canonical_id":"gesundheit:canonical-4905d7cb9c8f2d15c96be8c5","id":"public-e595cdf9452a45af7e6417e2","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Menopause Check in the context of longevity","score":21.05750067,"snippet":"The query asks for an evidence check on a 'Menopause Check' in the context of longevity. The provided knowledge contexts contain no direct information about such a test. Existing sources cover DNA tests for metabolism, alcohol intolerance, or collagen – not menopause. A menopause check measuring biomarkers like FSH, estradiol, or genetic variants in estrogen metabolism could theoretically indicate hormonal status. However, evidence linking it directly to longevity is weak. Menopause is a natural transition; hormone replacement therapy has benefits and risks that require individual assessment. Without robust clinical trials or guidelines recommending such a check for longevity, its predictive","sources":[],"title":"Evidence check: Menopause Check in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-e595cdf9452a45af7e6417e2/evidence-check-menopause-check-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The question of whether a longevity DNA test is useful during menopause is scientifically challenging. Menopause is a complex physiological transition driven by hormonal decline (especially estrogen). Some genetic variants – e.g., in ESR1 (estrogen receptor), VDR (vitamin D receptor), or CYP19A1 (aromatase) – have been associated with age at menopause, bone density, or vasomotor symptoms. However, effect sizes are small, and the predictive value for individual lifespan or 'healthy aging' is low. The provided context repeatedly states that direct-to-consumer (DTC) nutrigenetic tests like MyBody-X are clinically unvalidated and often overpromise. For menopause, no validated genetic test battery exists that reliably predicts longevity. Lifestyle factors (diet, exercise, stress management) and clinical biomarkers (blood pressure, lipids, bone density) are far more important. A DTC test may serve as a conversation starter with a healthcare provider, but not as a basis for clinical decisions. Evidence: mixed – mechanistic studies exist, but no robust clinical prediction models.","area":"gesundheit","canonical_id":"gesundheit:canonical-b08a22f65e8a4d3b998dcfdc","id":"public-57683bae34614a8a99df4009","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Longevity DNA Test in the context of menopause","score":21.00718,"snippet":"The question of whether a longevity DNA test is useful during menopause is scientifically challenging. Menopause is a complex physiological transition driven by hormonal decline (especially estrogen). Some genetic variants – e.g., in ESR1 (estrogen receptor), VDR (vitamin D receptor), or CYP19A1 (aromatase) – have been associated with age at menopause, bone density, or vasomotor symptoms. However, effect sizes are small, and the predictive value for individual lifespan or 'healthy aging' is low. The provided context repeatedly states that direct-to-consumer (DTC) nutrigenetic tests like MyBody-X are clinically unvalidated and often overpromise. For menopause, no validated genetic test batter","sources":[],"title":"Evidence check: Longevity DNA Test in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-57683bae34614a8a99df4009/evidence-check-longevity-dna-test-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"A 'Longevity DNA Test' often claims to predict lifespan or aging based on single SNPs (e.g., FTO, APOE, IL6). In the context of menopause, the evidence is weak: hormonal shifts (estrogen decline) have a far greater impact on metabolism, bone health, and cardiovascular risk than most tested variants. The provided context lacks any specific studies on longevity tests during menopause. While some GWAS associations exist (e.g., IL6 for inflammation), effect sizes are small and not deterministic. Such a test cannot replace a personalized menopause strategy. Evidence-based approaches—adequate calcium/vitamin D, resistance training, stress management, and possibly hormone therapy under medical guidance—are more effective. Therefore, the evidence level is 'marketing': there is no solid scientific basis for specific recommendations in menopause from these tests.","area":"gesundheit","canonical_id":"gesundheit:canonical-c8d9cc376331c5f33168adbe","id":"public-ef45f2fff1f8b668666432f1","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Longevity DNA Test in the context of Wechseljahre","score":20.85922759,"snippet":"A 'Longevity DNA Test' often claims to predict lifespan or aging based on single SNPs (e.g., FTO, APOE, IL6). In the context of menopause, the evidence is weak: hormonal shifts (estrogen decline) have a far greater impact on metabolism, bone health, and cardiovascular risk than most tested variants. The provided context lacks any specific studies on longevity tests during menopause. While some GWAS associations exist (e.g., IL6 for inflammation), effect sizes are small and not deterministic. Such a test cannot replace a personalized menopause strategy. Evidence-based approaches—adequate calcium/vitamin D, resistance training, stress management, and possibly hormone therapy under medical guid","sources":[],"title":"Evidence check: Longevity DNA Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ef45f2fff1f8b668666432f1/evidence-check-longevity-dna-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query asks for an evidence check on a 'Menopause Check' in the context of longevity. The provided context lacks any specific product or study on menopause testing. Menopause is a natural transition, not a disease. Genetic tests (e.g., for hormone receptor variants) or biomarkers (FSH, estradiol) cannot reliably predict timing or symptoms, nor directly influence longevity. Evidence for genetic predictors of menopause is weak (GWAS with small effect sizes). Hormone replacement therapy (HRT) has risk-benefit considerations but no clear life-extension effect. A 'Menopause Check' as a DNA test is currently marketing, not evidence-based medicine. Be cautious of overblown claims. For longevity, lifestyle factors (diet, exercise, stress management) are far more impactful. Cardiovascular risk factors (Lp(a), cholesterol) from the lipid context are relevant postmenopause, but not a menopause check per se. Conclusion: evidence grade 'marketing/unclear'. No validated sources in context.","area":"gesundheit","canonical_id":"gesundheit:canonical-33412cc1e8ecb1ca7debee26","id":"public-7a8d20f0e5b21e42c7801bea","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Menopause Check in the context of Langlebigkeit","score":20.68717963,"snippet":"The query asks for an evidence check on a 'Menopause Check' in the context of longevity. The provided context lacks any specific product or study on menopause testing. Menopause is a natural transition, not a disease. Genetic tests (e.g., for hormone receptor variants) or biomarkers (FSH, estradiol) cannot reliably predict timing or symptoms, nor directly influence longevity. Evidence for genetic predictors of menopause is weak (GWAS with small effect sizes). Hormone replacement therapy (HRT) has risk-benefit considerations but no clear life-extension effect. A 'Menopause Check' as a DNA test is currently marketing, not evidence-based medicine. Be cautious of overblown claims. For longevity,","sources":[],"title":"Evidence check: Menopause Check in the context of Langlebigkeit","url":"https://tikki.wiki/wissen/gesundheit/frage/public-7a8d20f0e5b21e42c7801bea/evidence-check-menopause-check-in-the-context-of-langlebigkeit/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"A menopause check (e.g., hormone or DNA test) can provide insights into hormonal status, but there is no strong evidence that it directly extends lifespan. Menopause is a natural transition; individual hormone changes vary. Some studies link age at menopause to certain health risks (e.g., cardiovascular), but causal effects on longevity are unclear. Tests marketed for 'anti-aging' or 'longevity' often rely on weak or mechanistic evidence. More actionable are medically supervised checks of blood pressure, lipids, bone density, and lifestyle factors. A standalone menopause check without clinical context may lead to misinterpretation or unnecessary worry. Evidence: mixed. Sources: none from provided context.","area":"gesundheit","canonical_id":"gesundheit:canonical-725db578f486d3fa13be5fe8","id":"public-c0b02784b2027a5aec99d5dd","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Can Menopause Check help with longevity?","score":20.63338843,"snippet":"A menopause check (e.g., hormone or DNA test) can provide insights into hormonal status, but there is no strong evidence that it directly extends lifespan. Menopause is a natural transition; individual hormone changes vary. Some studies link age at menopause to certain health risks (e.g., cardiovascular), but causal effects on longevity are unclear. Tests marketed for 'anti-aging' or 'longevity' often rely on weak or mechanistic evidence. More actionable are medically supervised checks of blood pressure, lipids, bone density, and lifestyle factors. A standalone menopause check without clinical context may lead to misinterpretation or unnecessary worry. Evidence: mixed. Sources: none from pro","sources":[],"title":"Can Menopause Check help with longevity?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c0b02784b2027a5aec99d5dd/can-menopause-check-help-with-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The query asks about a specific test called 'Fitness Vitality DNA' in the context of longevity, but the provided knowledge context does not mention this product directly. The documents cover general DNA tests for nutrition and longevity (e.g., DNA Longevity-Test), menopause hormone analysis, and nutrient checks. Therefore, no product-specific evidence can be derived. In general, the evidence for nutrigenetic tests targeting fitness and longevity is mixed: some markers (e.g., for lactose intolerance or certain vitamin needs) are well-supported, but many 'fitness genes' (such as ACTN3, PPARGC1A) show only weak associations with athletic performance or aging processes. Most of these tests rely on GWAS data with small effect sizes and have not been validated in randomized intervention trials. Moreover, longitudinal data on actual lifespan extension are lacking. A standalone DNA test cannot assess current biomarkers (e.g., inflammation, hormone levels) that are more directly relevant to longevity. Results should be considered exploratory, not diagnostic. Without specific product details, the evidence level remains unclear. Medical consultation is advised before implementing any changes.","area":"gesundheit","canonical_id":"gesundheit:canonical-7ee34fffe8a930e5b7953bbe","id":"public-3baf9819ff8377af629d3ace","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Fitness Vitality DNA in the context of longevity","score":19.78873638,"snippet":"The query asks about a specific test called 'Fitness Vitality DNA' in the context of longevity, but the provided knowledge context does not mention this product directly. The documents cover general DNA tests for nutrition and longevity (e.g., DNA Longevity-Test), menopause hormone analysis, and nutrient checks. Therefore, no product-specific evidence can be derived. In general, the evidence for nutrigenetic tests targeting fitness and longevity is mixed: some markers (e.g., for lactose intolerance or certain vitamin needs) are well-supported, but many 'fitness genes' (such as ACTN3, PPARGC1A) show only weak associations with athletic performance or aging processes. Most of these tests rely ","sources":[],"title":"Evidence check: Fitness Vitality DNA in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3baf9819ff8377af629d3ace/evidence-check-fitness-vitality-dna-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, family history) alongside menopausal status. Without integration into a clinical framework, the test's value remains limited. Safety note: Do not rely solely on a consumer genetic test for cardiovascular risk assessment during menopause; consult a healthcare provider.","area":"gesundheit","canonical_id":"gesundheit:canonical-ccbfaab7adb4f3d36ade19ed","id":"public-c55149e2ad24f5be7e24dcab","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check in the context of menopause","score":19.76631565,"snippet":"The combination of a Cardio Risk Check and menopause is not directly addressed in the provided context. The available information covers pharmacogenetics (CYP2D6, CYP2C19, VKORC1), hormone tests (without specifying cardiovascular markers), and microbiome/longevity tests. It is well established that menopause increases cardiovascular risk due to estrogen decline, but a consumer DNA or biomarker test alone cannot comprehensively assess this risk. Evidence for such tests in this specific context is unclear – there are no clinically validated studies demonstrating direct benefit. A proper Cardio Risk Check should incorporate traditional risk factors (blood pressure, lipids, glucose, smoking, fam","sources":[],"title":"Evidence check: Cardio Risk Check in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-c55149e2ad24f5be7e24dcab/evidence-check-cardio-risk-check-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The MyBody-X Fertility Check is not directly mentioned in the provided context. Based on available information about hormone tests (Body-Balance Check) and DNA tests, a fertility test typically measures hormones such as AMH, FSH, LH, estradiol, and progesterone. These markers are well-established in reproductive medicine (evidence: practice), but their link to longevity is scientifically weak. Longevity is influenced by factors like inflammation, oxidative stress, telomere length, and lifestyle—not directly by fertility hormones. Some studies suggest a correlation between later menopause and extended lifespan, but this is not causal and unsuitable for individual prediction. The test can assess reproductive health but should not be used as a longevity marker. Consumers should be aware that such tests do not replace clinical diagnosis and results need medical interpretation. Evidence: practice (for fertility) / unclear (for longevity).","area":"gesundheit","canonical_id":"gesundheit:canonical-72384d5b94272188cfb656bb","id":"public-d50a6ad4035f443e63ce27f6","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Fertility Check | Fruchtbarkeits-Test in the context of longevity","score":19.75116145,"snippet":"The MyBody-X Fertility Check is not directly mentioned in the provided context. Based on available information about hormone tests (Body-Balance Check) and DNA tests, a fertility test typically measures hormones such as AMH, FSH, LH, estradiol, and progesterone. These markers are well-established in reproductive medicine (evidence: practice), but their link to longevity is scientifically weak. Longevity is influenced by factors like inflammation, oxidative stress, telomere length, and lifestyle—not directly by fertility hormones. Some studies suggest a correlation between later menopause and extended lifespan, but this is not causal and unsuitable for individual prediction. The test can asse","sources":[],"title":"Evidence check: Fertility Check | Fruchtbarkeits-Test in the context of longevity","url":"https://tikki.wiki/wissen/gesundheit/frage/public-d50a6ad4035f443e63ce27f6/evidence-check-fertility-check-fruchtbarkeits-test-in-the-context-of-longevity/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"FOXO3 is a gene linked to longevity and cellular stress resistance. In the context of menopause, some GWAS have suggested that certain variants (e.g., rs2802292) may be associated with later age at natural menopause. However, the effect sizes are small and not clinically actionable. The evidence is primarily associative (GWAS), not mechanistic or interventional. A consumer DNA test for FOXO3 cannot reliably predict menopause timing or symptoms. Other genetic loci (e.g., MCM8, BRIP1) and non-genetic factors (e.g., smoking, BMI) play larger roles. Caveat: Direct-to-consumer tests lack regulatory approval for such predictions.","area":"gesundheit","canonical_id":"gesundheit:canonical-286e216651ea2da69a7a66d1","id":"public-eaaeec750edfad12b711fd15","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: FOXO3 in the context of Wechseljahre","score":19.56536356,"snippet":"FOXO3 is a gene linked to longevity and cellular stress resistance. In the context of menopause, some GWAS have suggested that certain variants (e.g., rs2802292) may be associated with later age at natural menopause. However, the effect sizes are small and not clinically actionable. The evidence is primarily associative (GWAS), not mechanistic or interventional. A consumer DNA test for FOXO3 cannot reliably predict menopause timing or symptoms. Other genetic loci (e.g., MCM8, BRIP1) and non-genetic factors (e.g., smoking, BMI) play larger roles. Caveat: Direct-to-consumer tests lack regulatory approval for such predictions.","sources":[],"title":"Evidence check: FOXO3 in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-eaaeec750edfad12b711fd15/evidence-check-foxo3-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"FOXO3 is a transcription factor involved in cellular stress resistance, metabolism, and longevity. In the context of menopause, FOXO3 variants have been associated with age at natural menopause in several GWAS (genome-wide association studies). For example, the rs2802292 G allele is linked to later menopause onset, but the effect size is small and the association is not deterministic. The evidence is primarily from GWAS and observational studies, not from randomized trials or clinical interventions. There is no strong evidence that a single FOXO3 SNP can reliably predict menopause timing or related health outcomes. Menopause age is polygenic and influenced by many lifestyle and environmental factors. Consumer DNA tests that claim to predict menopause based on FOXO3 alone are overstating the evidence. A conservative interpretation: FOXO3 is a candidate gene with modest, replicated associations, but not clinically actionable at this time.","area":"gesundheit","canonical_id":"gesundheit:canonical-20c345a02b44d9956ebc83f9","id":"public-2a0fed34200a844171bbb974","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: FOXO3 in the context of menopause","score":19.53972349,"snippet":"FOXO3 is a transcription factor involved in cellular stress resistance, metabolism, and longevity. In the context of menopause, FOXO3 variants have been associated with age at natural menopause in several GWAS (genome-wide association studies). For example, the rs2802292 G allele is linked to later menopause onset, but the effect size is small and the association is not deterministic. The evidence is primarily from GWAS and observational studies, not from randomized trials or clinical interventions. There is no strong evidence that a single FOXO3 SNP can reliably predict menopause timing or related health outcomes. Menopause age is polygenic and influenced by many lifestyle and environmental","sources":[],"title":"Evidence check: FOXO3 in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-2a0fed34200a844171bbb974/evidence-check-foxo3-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}